PLSM Pulsenmore Ltd.
Pulsenmore (PLSM) news
Pulsenmore Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PLSM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest Pulsenmore news
We have not published a story on Pulsenmore yet. When there is news, it will appear here.
Pulsenmore annual financials
| Line | FY2025 |
|---|---|
| Revenue | $12.5 million |
| Research and development | $5.4 million |
| Net income (loss) | -$5.0 million |
| Cash from operations | -$10.3 million |
| Cash and equivalents | $6.8 million |
Questions about Pulsenmore
What is the ticker symbol of Pulsenmore?
Pulsenmore Ltd. trades under the ticker PLSM on NASDAQ.
Where is Pulsenmore listed?
Pulsenmore Ltd. is listed on NASDAQ.
Which country or territory is Pulsenmore listed under?
Our directory records Pulsenmore Ltd. under United States.
Does aibio.space cover Pulsenmore?
aibio.space lists Pulsenmore Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
What was Pulsenmore's revenue last year?
$12.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Pulsenmore profitable?
Pulsenmore Ltd. reported a net loss of $5.0 million for the fiscal year ended Dec 31, 2025, and used $10.3 million of cash in operations, per its annual report to the SEC.
How much does Pulsenmore spend on research and development?
$5.4 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Pulsenmore have?
$6.8 million in cash at Dec 31, 2025, per its 20-F.
Investor discussion: Pulsenmore
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Reported a financing. SEC Form 6-K. Source
Stock chart
Listing details
- Company
- Pulsenmore Ltd.
- Ticker
- PLSM
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio